Induction chemotherapy with paclitaxel and cisplatin, followed by concomitant cisplatin and radiotherapy for the treatment of locally advanced nasopharyngeal carcinoma.

Journal of the Egyptian National Cancer Institute

Volumn 18, Issue 4, 2006, Pages 348-356

  Mostafa, Ehab ^a   Nasar, Mohamed N ^a   Rabie, Nabil A ^a   Ibrahim, Samer A ^a   Barakat, Hammad M ^a   Rabie, Amro N ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; PACLITAXEL;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CLINICAL TRIAL; DISEASE COURSE; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NASOPHARYNX TUMOR; PATHOLOGY; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; RADIOTHERAPY; SQUAMOUS CELL CARCINOMA; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PACLITAXEL; PATIENT COMPLIANCE; RADIOTHERAPY; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 41749096627     PISSN: 11100362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)